Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Japan Wound Care Management Medical Equipment Industry Report

Published by: Global Markets Direct

Published: May. 2, 2008 - 322 Pages


Table of Contents


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Definitions
2.2.1 Wound Care Management
3 Healthcare Sector Review
3.1 Healthcare Expenditure
3.2 Healthcare Infrastructure
3.3 Healthcare Policy
4 Wound Care Management in Japan
4.1 Wound Care Management Overall Revenues (2000-2012)
4.2 Wound Care Management Overall Volume (2000-2012)
4.3 Wound Care Management Overall Company Shares (2005-2006)
5 Wound Closure Devices in Japan
5.1 Wound Closure Devices Overall Revenues (2000-2012)
5.1.1 Skin Closure Devices Overall Revenues (2000-2012)
5.1.2 Tissue Sealants Overall Revenues (2000-2012)
5.1.3 Hemostats Overall Revenues (2000-2012)
5.2 Wound Closure Devices Overall Volume (2000-2012)
5.2.1 Tissue Sealants Overall Volume (2000-2012)
5.2.2 Skin Closure Devices Overall Volume (2000-2012)
5.2.3 Hemostats Overall Volume (2000-2012)
5.3 Wound Closure Devices Average Price (2000-2012)
5.3.1 Hemostats Average Price (2000-2012)
5.3.2 Tissue Sealants Average Price (2000-2012)
5.3.3 Skin Closure Devices Average Price (2000-2012)
5.4 Wound Closure Devices Distribution Share (2000-2012)
5.5 Wound Closure Devices Company Share (2000-2012)
6 Ostomy in Japan
6.1 Ostomy Overall Revenue (2000-2012)
6.2 Ostomy Overall Volume (2000-2012)
6.3 Ostomy Average Price (2000-2012)
6.4 Ostomy Distribution Share (2005-2006)
6.5 Ostomy Company Share (2005-2006)
7 Advanced Wound Management in Japan
7.1 Advanced Wound Management Overall Revenue (2000-2012)
7.2 Advanced Wound Management Overall Volume (2000-2012)
7.3 Advanced Wound Management Average Price (2000-2012)
7.4 Advanced Wound Management Distribution Share (2005-2006)
7.5 Advanced Wound Management Company Share (2005-2006)
8 Traditional Wound Management in Japan
8.1 Traditional Wound Management Overall Revenue (2000-2012)
8.2 Traditional Wound Management Overall Volume (2000-2012)
8.3 Traditional Wound Management Average Price (2000-2012)
8.4 Traditional Wound Management Distribution Share (2000-2012)
8.5 Traditional Wound Management Company Share (2000-2012)
9 Compression Therapy in Japan
9.1 Compression Therapy Overall Revenue (2000-2012)
9.2 Compression Therapy Category Volume (2000-2012)
9.3 Compression Therapy Average Price (2000-2012)
9.4 Compression Therapy Distribution Share (2000-2012)
9.5 Compression Therapy Company Share (2000-2012)
10 Baxter International Company Profile
10.1 Company Overview
10.2 Business Overview
10.2.1 BioScience
10.2.2 Medication Delivery
10.2.3 Renal
10.2.4 Products
10.2.5 History
10.3 Value Chain Analysis
10.3.1 Manufacturing
10.3.2 Product Development
10.3.3 Sales and Marketing
10.4 SWOT Analysis
10.4.1 Baxter International Inc. Strengths
10.4.2 Baxter International Inc. Weaknesses
10.4.3 Baxter International Inc. Opportunities
10.4.4 Baxter International Inc. Threats
10.5 Financial and Operational Review
10.6 Locations And Subsidiaries
10.7 Financial Deals Landscape
10.7.1 Baiyunshan And Baxter Form A Joint Venture In China
10.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration
10.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital
10.7.4 B. Braun Acquires Renal Therapy Business Of Baxter
10.7.5 Innovata signs a license agreement with Baxter International
10.7.6 Kuros Biosurgery Signs An Agreement With Baxter International
10.7.7 Gambro Signs An Agreement With Baxter
10.7.8 Baxter Healthcare And Gambro Enter Into An Agreement
10.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System
10.7.10 Baxter International And Kaketsuken Enter Into Agreement
10.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful
10.8 Recent Developments
10.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007
10.8.2 Dec 18, 2007: Baxter Elects CFO
10.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend
10.8.4 Aug 01, 2007: Baxter Elects New Board Director
10.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend
10.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization
10.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend
10.8.8 Nov 28, 2006: Baxter Announces Annual Dividend
10.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America
10.9 Baxter International Inc. Pipeline Products
10.9.1 Next-Generation Home Hemodialysis Machine
11 Covidien Ltd./Tyco Healthcare Company Profile
11.1 Company Overview
11.2 Business Overview
11.2.1 Imaging Solutions
11.2.2 Medical Devices
11.2.3 Medical Supplies
11.2.4 Pharmaceutical Products
11.2.5 Retail Products
11.2.6 Products
11.2.7 History
11.3 Value Chain Analysis
11.3.1 Manufacturing
11.3.2 Product Development
11.3.3 Sales and Marketing
11.4 SWOT Analysis
11.4.1 Covidien Ltd./Tyco Healthcare Strengths
11.4.2 Covidien Ltd./Tyco Healthcare Weaknesses
11.4.3 Covidien Ltd./Tyco Healthcare Opportunities
11.4.4 Covidien Ltd./Tyco Healthcare Threats
11.5 Financial and Operational Review
11.5.1 Financial Statements
11.5.2 Financial Ratios
11.6 Locations And Subsidiaries
11.7 Financial Deals Landscape
11.7.1 Covidien Signs An Agreement With Allergan
11.7.2 Covidien Acquires Scandius Biomedical
11.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million
11.7.4 Covidien And BioSynthema Enter Into Licensing Agreement
11.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien
11.7.6 Covidien To Sell European Incontinence Business
11.7.7 Covidien To Acquire Tissue Science Laboratories
11.8 Recent Developments
11.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007
11.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend
11.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case
11.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results
11.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend
11.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results
11.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results
11.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent
11.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend
11.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results
11.9 Covidien Ltd./Tyco Healthcare Pipeline Products
11.9.1 PleuraSeal Lung Sealant System
11.9.2 Sandman Intro CPAP Device
12 3M Company Profile
12.1 Company Overview
12.2 Business Overview
12.2.1 Consumer and Office
12.2.2 Display and Graphics
12.2.3 Electro and Communications
12.2.4 Health Care
12.2.5 Industrial and Transportation
12.2.6 Safety, Security and Protection Services
12.2.7 Products
12.3 Value Chain Analysis
12.3.1 Manufacturing
12.3.2 Product Development
12.3.3 Sales and Marketing
12.4 SWOT Analysis
12.4.1 3M Company Strengths
3M Company Weaknesses
3M Company Opportunities
3M Company Threats
12.5 Financial and Operational Review
12.6 Locations And Subsidiaries
12.7 Financial Deals Landscape
12.7.1 3M Canada Acquires Les Entreprises Solumed
12.7.2 3M Acquires Bondo
12.7.3 3M Acquires Lingualcare
12.7.4 3M Acquires Abzil Industria E Comercio
12.7.5 3M Acquires Neo Plast
12.7.6 3M Acquires Assets Of DMS Chile
12.7.7 3M Acquires Business Of Innovative Paper Technologies
12.7.8 3M Acquires Powell
12.7.9 Gen-Probe Signs An Agreement With 3M Company
12.7.10 3M Acquires Acolyte Biomedica
12.7.11 3M Acquires Sealed Air Corp.'S Interest In Polymask Corp.
12.7.12 3M Sells Its Pharmaceutical Business To Meda AB
12.7.13 3M Acquires SoftMed Systems
12.7.14 3M Sells its Pharmaceuticals Business to Graceway
12.7.15 Gen-Probe Signs An Agreement With 3M
12.7.16 3M Sells its Pharmaceutical Operations in the Asia Pacific Region to Ironbridge Capital and Archer Capital
12.7.17 3M Acquires Biotrace International
12.7.18 Ekahau Secures $16 Million In Additional Funding
12.7.19 3M Acquires Brontes Technologies
12.7.20 3M acquires Nylonge Corp
12.7.21 3M Signs An Agreement With ClozeX Medical
12.7.22 3M Acquires OMNII Oral Pharmaceuticals
12.7.23 3M Sells Pharmaceutical Operations In The United States To Graceway
12.7.24 3M Sells Pharmaceutical Business In Europe To Meda AB
12.7.25 3M Sells Pharmaceutical Operations In The Asia Pacific To Ironbridge and Archer Capital
12.7.26 3M Acquires Accuspray Application Technologies Inc.
12.7.27 3M to acquire Rochford Thompson Equipment
12.7.28 3M To Acquire Aearo Technologies From Permira
12.7.29 Permira To Sell Aearo Technologies To 3M
12.8 Recent Developments
12.8.1 Mar 31, 2008: HighJump Software Introduces Survey Management Solution for Direct Store Delivery Businesses
12.8.2 Mar 24, 2008: Brazil's Companhia de Transmissao de Energia Eletrica Paulista Chooses 3M ACCR for Upgrade of Line Over Parana River in Sao Paulo State
12.8.3 Mar 19, 2008: 3M to Headquarter Optical Systems Business in Asia
12.8.4 Mar 19, 2008: 3M To Headquarter Optical Systems Business In North Asia
12.8.5 Feb 11, 2008: 3M Increases Dividend for the 50th Straight Year
12.8.6 Nov 12, 2007: 3M Declares Quarterly Dividend
12.8.7 Oct 24, 2007: 3M And Sanyo Settle Suit On Lithium Ion Battery
12.8.8 Aug 13, 2007: 3M Declares Quarterly Dividend
12.8.9 May 08, 2007: 3M Declares Quarterly Dividend
12.8.10 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests
13 Ethicon, Inc. Company Profile
13.1 Company Overview
13.2 Business Overview
13.2.1 Products
13.3 Locations And Subsidiaries
13.4 Financial Deals Landscape
13.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON
13.4.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON
13.4.3 ETHICON Acquires Vascular Control Systems
13.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON
14 Smith & Nephew Plc Company Profile
14.1 Company Overview
14.2 Business Overview
14.2.1 Advanced Wound Management
14.2.2 Endoscopy
14.2.3 Reconstruction
14.2.4 Trauma and Clinical Therapies
14.2.5 Products
14.2.6 History
14.3 Value Chain Analysis
14.3.1 Manufacturing
14.3.2 Product Development
14.3.3 Sales and Marketing
14.4 SWOT Analysis
14.4.1 Smith & Nephew Plc Strengths
14.4.2 Smith & Nephew Plc Weaknesses
14.4.3 Smith & Nephew Plc Opportunities
14.4.4 Smith & Nephew Plc Threats
14.5 Financial and Operational Review
14.6 Locations And Subsidiaries
14.7 Other Locations & Subsidiaries
14.8 Financial Deals Landscape
14.8.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein
14.8.2 Smith & Nephew Signs An Agreement With Universal Hospital Services
14.8.3 Smith & Nephew Acquires Plus Orthopedics Holding
14.8.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement
14.8.5 Smith & Nephew Acquires BlueSky Medical Group
14.8.6 Smith & Nephew Enters Into An Agreement With Covalon
14.8.7 Smith & Nephew Signs An Agreement With UDL Laboratories
14.8.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew
14.8.9 Smith & Nephew Acquires Osteobiologics
14.8.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement
14.8.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity
14.8.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew
14.8.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies
14.8.14 Smith & Nephew Signs An Agreement With ORTHOsoft
14.8.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement
14.8.16 Smith & Nephew Acquires VERSAJET From HydroCision
14.8.17 Smith & Nephew Terminates Acquisition Of Biomet
14.9 Recent Developments
14.9.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend
14.9.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results
14.9.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America’s Hip Generation
14.9.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM
14.9.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation Nails
14.9.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend
14.9.7 May 03, 2007: Smith & Nephew Appoints New CEO
14.10 Smith & Nephew Plc Pipeline Products
14.10.1 R3 Modular resurfacing Acetabular system
14.10.2 R3 Ceramic-on-ceramic Acetabular System
15 Regulation System
15.1 Medical Equipment Approval Process
15.1.1 Market Authorization Holder (MAH)
15.1.2 Classification and Pre-Market Approval of Medical Devices
15.1.3 Third Party Certification for Controlled Medical Devices
15.1.4 PMDA Approval for Highly Controlled Medical Devices
15.1.5 Registration Time
15.1.6 Registration Fee
15.1.7 Post Marketing Surveillance
15.1.8 Labeling and Packaging
16 Pricing and Reimbursement
16.1 Market Pricing
16.2 Reimbursement Policies
16.3 Reimbursement Classes
16.3.1 Class A
16.3.2 Class B
16.3.3 Class C
16.3.4 Class F
16.4 Request for Reimbursement
16.5 Reduction in Reimbursement for Medical Devices and Drugs
17 Distribution Structure
18 APPENDIX
18.1 Global Markets Direct Research Methodology
18.2 Coverage
18.3 Secondary Research
18.4 Primary Research
18.5 Models
18.6 Forecasts
18.7 Expert Panels
18.8 Currency Conversion
18.9 Contact Us
18.10 Disclaimer
1.1 List of Tables
Table 1: Healthcare Expenditure in Japan, 2000 - 2005
Table 2: Number of Healthcare Institutions in Japan, 1995 - 2004
Table 3: Number of Hospital Beds in Japan, 1995 - 2004
Table 4: Number of Medical Personnel in Japan, 1995 - 2004
Table 5: Number of Doctors by Specialty in Japan, 2003-2007
Table 6: Number of Medical Care Institutions and Beds in Japan, 2000 - 2004
Table 7: Wound Care Management, Japan, Overall Revenues ($ mn), 2000-2012
Table 8: Wound Care Management, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Table 9: Wound Care Management, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Table 10: Wound Care Management, Japan, Category Revenues ($ mn), 2000-2012
Table 11: Wound Care Management, Japan, Category Revenues ($ mn), Historic, 2000-2007
Table 12: Wound Care Management, Japan, Category Revenues ($ mn), Forecast, 2007-2012
Table 13: Wound Care Management, Japan, Category Volume (Units), 2000-2012
Table 14: Wound Care Management, Japan, Category Volume (Units), Historic, 2000-2007
Table 15: Wound Care Management, Japan, Category Volume (Units), Forecast, 2007-2012
Table 16: Wound Care Management, Japan, Company Share by Revenue ($ mn), 2005-2006
Table 17: Wound Closure Devices, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Table 18: Wound Closure Devices, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Table 19: Wound Closure Devices, Japan, Revenue by Segment ($ mn), Historic, 2000-2007
Table 20: Wound Closure Devices, Japan, Revenue by Segment ($ mn), Forecast, 2007-2012
Table 21: Skin Closure Devices, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Table 22: Skin Closure Devices, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Table 23: Tissue Sealants, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Table 24: Tissue Sealants, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Table 25: Hemostats, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Table 26: Hemostats, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Table 27: Wound Closure Devices, Japan, Overall Volume (Units), Historic, 2000-2007
Table 28: Wound Closure Devices, Japan, Overall Volume (Units), Forecast, 2007-2012
Table 29: Tissue Sealants, Japan, Overall Volume (Units), Historic, 2000-2007
Table 30: Tissue Sealants, Japan, Overall Volume (Units), Forecast, 2007-2012
Table 31: Skin Closure Devices, Japan, Overall Volume (Units), Historic, 2000-2007
Table 32: Skin Closure Devices, Japan, Overall Volume (Units), Forecast, 2007-2012
Table 33: Hemostats, Japan, Overall Volume (Units), Historic, 2000-2007
Table 34: Hemostats, Japan, Overall Volume (Units), Forecast, 2007-2012
Table 35: Hemostats, Japan, Average Price ($), Historic, 2000-2007
Table 36: Hemostats, Japan, Average Price ($), Forecast, 2007-2012
Table 37: Tissue Sealants, Japan, Average Price ($), Historic, 2000-2007
Table 38: Tissue Sealants, Japan, Average Price ($), Forecast, 2007-2012
Table 39: Skin Closure Devices, Japan, Average Price ($), Historic, 2000-2007
Table 40: Skin Closure Devices, Japan, Average Price ($), Forecast, 2007-2012
Table 41: Wound Closure Devices, Japan, Distribution Share by Revenue ($ mn), 2005-2006
Table 42: Wound Closure Devices, Japan, Company Share by Revenue ($ mn), 2005-2006
Table 43: Ostomy, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Table 44: Ostomy, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Table 45: Ostomy, Japan, Overall Volume (Units), Historic, 2000-2007
Table 46: Ostomy, Japan, Overall Volume (Units), Forecast, 2007-2012
Table 47: Ostomy, Japan, Average Price ($), Historic, 2000-2007
Table 48: Ostomy, Japan, Average Price ($), Forecast, 2007-2012
Table 49: Ostomy, Japan, Distribution Share by Revenue ($ mn), 2005-2006
Table 50: Ostomy, Japan, Company Share by Revenue ($ mn), 2005-2006
Table 51: Advanced Wound Management, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Table 52: Advanced Wound Management, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Table 53: Advanced Wound Management, Japan, Overall Volume (Units), Historic, 2000-2007
Table 54: Advanced Wound Management, Japan, Overall Volume (Units), Forecast, 2007-2012
Table 55: Advanced Wound Management, Japan, Average Price ($), Historic, 2000-2007
Table 56: Advanced Wound Management, Japan, Average Price ($), Forecast, 2007-2012
Table 57: Advanced Wound Management, Japan, Distribution Share by Revenue ($ mn), 2005-2006
Table 58: Advanced Wound Management, Japan, Company Share by Revenue ($ mn), 2005-2006
Table 59: Traditional Wound Management, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Table 60: Traditional Wound Management, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Table 61: Traditional Wound Management, Japan, Overall Volume (Units), Historic, 2000-2007
Table 62: Traditional Wound Management, Japan, Overall Volume (Units), Forecast, 2007-2012
Table 63: Traditional Wound Management, Japan, Average Price ($), Historic, 2000-2007
Table 64: Traditional Wound Management, Japan, Average Price ($), Forecast, 2007-2012
Table 65: Traditional Wound Management, Japan, Distribution Share by Revenue ($ mn), 2005-2006
Table 66: Traditional Wound Management, Japan, Company Share by Revenue ($ mn), 2005-2006
Table 67: Compression Therapy, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Table 68: Compression Therapy, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Table 69: Compression Therapy, Japan, Overall Volume (Units), Historic, 2000-2007
Table 70: Compression Therapy, Japan, Overall Volume (Units), Forecast, 2007-2012
Table 71: Compression Therapy, Japan, Average Price ($), Historic, 2000-2007
Table 72: Compression Therapy, Japan, Average Price ($), Forecast, 2007-2012
Table 73: Compression Therapy, Japan, Distribution Share by Revenue ($ mn), 2005-2006
Table 74: Compression Therapy, Japan, Company Share by Revenue ($ mn), 2005-2006
Table 75: Baxter International Inc., SWOT Analysis, 2006
Table 76: Baxter International Inc., Financial Statements, USD Million, 2002-2006
Table 77: Baxter International Inc., Financial Ratios, USD Million, 2002-2006
Table 78: Baxter International Inc., Other Locations
Table 79: Baxter International Inc., Subsidiaries
Table 80: Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007
Table 81: Covidien Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007
Table 82: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD Million, 2003-2007
Table 83: Covidien Ltd./Tyco Healthcare, Other Locations
Table 84: Covidien Ltd./Tyco Healthcare, Subsidiaries
Table 85: 3M Company, SWOT Analysis, 2006
Table 86: 3M Company, Financial Statements, USD Million, 2002-2006
Table 87: 3M Company, Financial and Operational Overview, USD Million, 2002-2006
Table 88: 3M Company, Subsidiaries
Table 89: Ethicon, Inc., Other Locations
Table 90: Ethicon, Inc., Subsidiaries
Table 91: Smith & Nephew Plc, SWOT Analysis, 2006
Table 92: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006
Table 93: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006
Table 94: Smith & Nephew Plc, Other Locations
Table 95: Registration Processing Time for Medical Devices in Japan, 2007
Table 96: Product Registration Fee for Medical Devices in Japan, 2007
Table 97: Currency Conversion from USD to Local Currency at 2007 Constant Rate
1.1 List of Figures
Figure 1: Healthcare Expenditure in Japan, 2000 - 2005
Figure 2: Government and Private Healthcare Expenditure in Japan, 2005
Figure 3: Wound Care Management, Japan, Overall Revenues ($ mn), 2000-2012
Figure 4: Wound Care Management, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Figure 5: Wound Care Management, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 6: Wound Care Management, Japan, Category Revenues ($ mn), 2000-2012
Figure 7: Wound Care Management, Japan, Category Revenues ($ mn), Historic, 2000-2007
Figure 8: Wound Care Management, Japan, Category Revenues ($ mn), Forecast, 2007-2012
Figure 9: Wound Care Management, Japan, Category Volume (Units), 2000-2012
Figure 10: Wound Care Management, Japan, Category Volume (Units), Historic, 2000-2007
Figure 11: Wound Care Management, Japan, Category Volume (Units), Forecast, 2007-2012
Figure 12: Wound Care Management, Japan, Company Share (%), 2006
Figure 13: Wound Closure Devices, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Figure 14: Wound Closure Devices, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 15: Wound Closure Devices, Japan, Revenue by Segment ($ mn), Historic, 2000-2007
Figure 16: Wound Closure Devices, Japan, Revenue by Segment ($ mn), Forecast, 2007-2012
Figure 17: Skin Closure Devices, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Figure 18: Skin Closure Devices, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 19: Tissue Sealants, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Figure 20: Tissue Sealants, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 21: Hemostats, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Figure 22: Hemostats, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 23: Wound Closure Devices, Japan, Overall Volume (Units), Historic, 2000-2007
Figure 24: Wound Closure Devices, Japan, Overall Volume (Units), Forecast, 2007-2012
Figure 25: Tissue Sealants, Japan, Overall Volume (Units), Historic, 2000-2007
Figure 26: Tissue Sealants, Japan, Overall Volume (Units), Forecast, 2007-2012
Figure 27: Skin Closure Devices, Japan, Overall Volume (Units), Historic, 2000-2007
Figure 28: Skin Closure Devices, Japan, Overall Volume (Units), Forecast, 2007-2012
Figure 29: Hemostats, Japan, Overall Volume (Units), Historic, 2000-2007
Figure 30: Hemostats, Japan, Overall Volume (Units), Forecast, 2007-2012
Figure 31: Hemostats, Japan, Average Price ($), Historic, 2000-2007
Figure 32: Hemostats, Japan, Average Price ($), Forecast, 2007-2012
Figure 33: Tissue Sealants, Japan, Average Price ($), Historic, 2000-2007
Figure 34: Tissue Sealants, Japan, Average Price ($), Forecast, 2007-2012
Figure 35: Skin Closure Devices, Japan, Average Price ($), Historic, 2000-2007
Figure 36: Skin Closure Devices, Japan, Average Price ($), Forecast, 2007-2012
Figure 37: Wound Closure Devices, Japan, Distribution Share (%), 2006
Figure 38: Wound Closure Devices, Japan, Company Share (%), 2006
Figure 39: Ostomy, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Figure 40: Ostomy, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 41: Ostomy, Japan, Overall Volume (Units), Historic, 2000-2007
Figure 42: Ostomy, Japan, Overall Volume (Units), Forecast, 2007-2012
Figure 43: Ostomy, Japan, Average Price ($), Historic, 2000-2007
Figure 44: Ostomy, Japan, Average Price ($), Forecast, 2007-2012
Figure 45: Ostomy, Japan, Company Share (%), 2006
Figure 46: Advanced Wound Management, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Figure 47: Advanced Wound Management, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 48: Advanced Wound Management, Japan, Overall Volume (Units), Historic, 2000-2007
Figure 49: Advanced Wound Management, Japan, Overall Volume (Units), Forecast, 2007-2012
Figure 50: Advanced Wound Management, Japan, Average Price ($), Historic, 2000-2007
Figure 51: Advanced Wound Management, Japan, Average Price ($), Forecast, 2007-2012
Figure 52: Advanced Wound Management, Japan, Distribution Share (%), 2006
Figure 53: Advanced Wound Management, Japan, Company Share (%), 2006
Figure 54: Traditional Wound Management, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Figure 55: Traditional Wound Management, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 56: Traditional Wound Management, Japan, Overall Volume (Units), Historic, 2000-2007
Figure 57: Traditional Wound Management, Japan, Overall Volume (Units), Forecast, 2007-2012
Figure 58: Traditional Wound Management, Japan, Average Price ($), Historic, 2000-2007
Figure 59: Traditional Wound Management, Japan, Average Price ($), Forecast, 2007-2012
Figure 60: Traditional Wound Management, Japan, Distribution Share (%), 2006
Figure 61: Traditional Wound Management, Japan, Company Share (%), 2006
Figure 62: Compression Therapy, Japan, Overall Revenues ($ mn), Historic, 2000-2007
Figure 63: Compression Therapy, Japan, Overall Revenues ($ mn), Forecast, 2007-2012
Figure 64: Compression Therapy, Japan, Overall Volume (Units), Historic, 2000-2007
Figure 65: Compression Therapy, Japan, Overall Volume (Units), Forecast, 2007-2012
Figure 66: Compression Therapy, Japan, Average Price ($), Historic, 2000-2007
Figure 67: Compression Therapy, Japan, Average Price ($), Forecast, 2007-2012
Figure 68: Compression Therapy, Japan, Distribution Share (%), 2006
Figure 69: Compression Therapy, Japan, Company Share (%), 2006
Figure 70: Baxter International Inc., Value Chain Analysis
Figure 71: Covidien Ltd./Tyco Healthcare, Value Chain Analysis
Figure 72: 3M Company, Value Chain Analysis
Figure 73: Smith & Nephew Plc, Value Chain Analysis
Figure 74: Medical Device Classification in Japan, 2007
Figure 75: Approval Process for Controlled Medical Devices in Japan, 2007
Figure 76: Approval Process for Highly Controlled Medical Devices in Japan, 2007
Figure 77: Health Insurance Reimbursement Process in Japan, 2007
Figure 78: Distribution Structure for Medical Equipment in Japan, 2007
Figure 79: Global Markets Direct Methodology


Abstract

Japan Wound Care Management Medical Equipment Industry Report

Summary

This report is an essential source for in-depth information and data relating to Japan wound care management medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of thewound care management in Japan

Scope
  • The report provides sector information broken down into detailed categories and segments in country. • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the industry at a global level, with break downs for the country
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


advertise with us

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008